These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19875130)

  • 21. PET network abnormalities and cognitive decline in patients with mild cognitive impairment.
    Devanand DP; Habeck CG; Tabert MH; Scarmeas N; Pelton GH; Moeller JR; Mensh BD; Tarabula T; Van Heertum RL; Stern Y
    Neuropsychopharmacology; 2006 Jun; 31(6):1327-34. PubMed ID: 16292330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural correlates of the Clock Drawing Test performance in Alzheimer's disease: a FDG-PET study.
    Lee DY; Seo EH; Choo IH; Kim SG; Lee JS; Lee DS; Jhoo JH; Kim KW; Youn JC; Woo JI
    Dement Geriatr Cogn Disord; 2008; 26(4):306-13. PubMed ID: 18841015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.
    Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S
    Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional representation of olfactory impairment in early Alzheimer's disease.
    Förster S; Vaitl A; Teipel SJ; Yakushev I; Mustafa M; la Fougère C; Rominger A; Cumming P; Bartenstein P; Hampel H; Hummel T; Buerger K; Hundt W; Steinbach S
    J Alzheimers Dis; 2010; 22(2):581-91. PubMed ID: 20847402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
    Teipel SJ; Willoch F; Ishii K; Bürger K; Drzezga A; Engel R; Bartenstein P; Möller HJ; Schwaiger M; Hampel H
    Neurobiol Aging; 2006 May; 27(5):681-90. PubMed ID: 15908048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease.
    Arlt S; Brassen S; Jahn H; Wilke F; Eichenlaub M; Apostolova I; Wenzel F; Thiele F; Young S; Buchert R
    Eur J Nucl Med Mol Imaging; 2009 Jul; 36(7):1090-100. PubMed ID: 19219430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.
    Gardener SL; Sohrabi HR; Shen KK; Rainey-Smith SR; Weinborn M; Bates KA; Shah T; Foster JK; Lenzo N; Salvado O; Laske C; Laws SM; Taddei K; Verdile G; Martins RN
    J Alzheimers Dis; 2016 Mar; 52(2):661-72. PubMed ID: 27031482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.
    Scarmeas N; Habeck CG; Zarahn E; Anderson KE; Park A; Hilton J; Pelton GH; Tabert MH; Honig LS; Moeller JR; Devanand DP; Stern Y
    Neuroimage; 2004 Sep; 23(1):35-45. PubMed ID: 15325350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain changes within the visuo-spatial attentional network in posterior cortical atrophy.
    Cerami C; Crespi C; Della Rosa PA; Dodich A; Marcone A; Magnani G; Coppi E; Falini A; Cappa SF; Perani D
    J Alzheimers Dis; 2015; 43(2):385-95. PubMed ID: 25114070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease.
    Newberg A; Cotter A; Udeshi M; Brinkman F; Glosser G; Alavi A; Clark C
    Nucl Med Commun; 2003 Jul; 24(7):785-90. PubMed ID: 12813197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment.
    Nishi H; Sawamoto N; Namiki C; Yoshida H; Dinh HD; Ishizu K; Hashikawa K; Fukuyama H
    J Neuroimaging; 2010 Jan; 20(1):29-36. PubMed ID: 19018949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Alzheimer disease-like pattern of 18F-FDG and fasting plasma glucose levels in cognitively normal volunteers.
    Ishibashi K; Onishi A; Fujiwara Y; Ishiwata K; Ishii K
    J Nucl Med; 2015 Feb; 56(2):229-33. PubMed ID: 25572094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA; Monserratt L; Harwood D; Mandelkern M; Cummings JL; Sultzer DL
    Arch Neurol; 2007 Jul; 64(7):1015-20. PubMed ID: 17620493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between episodic memory and resting-state brain functional connectivity network in patients with Alzheimer's disease and mild cognition impairment].
    Wu QJ; Guo ZJ; Liu SE; Yu HQ; Chen J; Yang HM
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1795-800. PubMed ID: 24124712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of regional brain hypometabolism associated with knowledge of semantic features and categories in Alzheimer's disease.
    Zahn R; Garrard P; Talazko J; Gondan M; Bubrowski P; Juengling F; Slawik H; Dykierek P; Koester B; Hull M
    J Cogn Neurosci; 2006 Dec; 18(12):2138-51. PubMed ID: 17129196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesion-symptom mapping of a complex figure copy task: A large-scale PCA study of the BCoS trial.
    Chen H; Pan X; Lau JKL; Bickerton WL; Pradeep B; Taheri M; Humphreys G; Rotshtein P
    Neuroimage Clin; 2016; 11():622-634. PubMed ID: 27182489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
    Brugnolo A; Orso B; Girtler N; Ferraro PM; Arnaldi D; Mattioli P; Massa F; Famà F; Argenti L; Biffa G; Morganti W; Buonopane S; Uccelli A; Morbelli S; Pardini M
    Cortex; 2024 Feb; 171():413-422. PubMed ID: 38113612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment.
    Perneczky R; Hartmann J; Grimmer T; Drzezga A; Kurz A
    J Geriatr Psychiatry Neurol; 2007 Jun; 20(2):84-8. PubMed ID: 17548777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism.
    Seo SW; Cho SS; Park A; Chin J; Na DL
    J Neuroimaging; 2009 Jul; 19(3):213-9. PubMed ID: 19021838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.